D100 - Dose Banded Chemotherapy
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £18,000,000 |
|---|---|
| Status | planning |
| Category (CPV) | 33600000 |
| OCID | ocds-h6vhtk-0510a6 |
description
Framework for the Supply of Dose Banded Chemotherapy Products as listed in the Tender specification and commercial schedule
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 12 May 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 020384-2025 |
| 12 May 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 020394-2025 |
more from University Hospitals of Derby and Burton NHS Foundation Trust
- Wifi Leased Lines · £19,466 · 24 Jul 2026
- Provision of Tonometer Probes · £60,000 · 22 Jul 2026
- Water Testing Services · 15 Jul 2026
- Cardiac MRI Renewal · 15 Jul 2026
- Renewal of Spark Connect WiFi for Burton Accommodation · 15 Jul 2026
- Renewal of DEMS 360 PAYU Camera Software · 15 Jul 2026
- Maintenance - Floor rail x-ray therapy system · 10 Jul 2026
- Service Contract and extended warranty · 8 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.